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Background and purpose: The purpose of the study was to evaluate the frequency of interictal
depressive symptoms and different subtypes of depressive disorders according to 10th
revision of the International Classiﬁcation of Diseases (ICD-10) criteria in patients with
epilepsy and its association with the type of epilepsy.
Material and methods: 289 outpatients with epilepsy (169 females, 120 males) aged 18–82
years completed Beck Depression Inventory (BDI). Subjects who scored >11 in BDI were
further evaluated by the psychiatrist according to the ICD-10 diagnostic criteria.
Results: 41.9% (121) of the 289 participants scored >11 in BDI. 104 (85.9%) patients who scored
>11 in BDI had comorbid mental disorders according to ICD-10 criteria. The most common
were organic mood disorders (F06.3 – 31.4%), depressive episode (F32 – 22.3%) and dysthymia
(F34.1 – 9.1%) There were no differences in the prevalence of depression and subtypes of
depression in patients with certain epilepsy types. Depression was diagnosed before
entering the study in only one third of patients with ﬁnal diagnosis of depression.
Conclusions: Our results conﬁrm the prevailing view that interictal depression is common in
epilepsy patients. Depression remains underrecognized and undertreated in patients with
epilepsy.
# 2015 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http://www.elsevier.com/locate/pjnns1. Introduction
Depression is one of the most frequent psychiatric disorders in
epileptic patients [1–4]. The relationship between depression
and epilepsy has been extensively studied in recent decades.
A large body of research indicates that there is the increased* Corresponding author at: Klinika Neurologii, Szpital Uniwersytecki w
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compared with healthy controls. The prevalence of interictal
depressive disorder in epileptic patients has been shown to
range between 9% and 62% [1,5], depending on the sample
population and the methods of assessment, and is higher than
in a matched population of normal controls. The psychiatric
comorbidities in people with epilepsy have important clinical Krakowie, ul. Botaniczna 3, 31-503 Kraków, Poland.
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presence of depression in patients with epilepsy exerts a
stronger impact over quality of life than other clinical variables,
including types and frequency of seizures [6]. Proper diagnosis
and treatment of depression in epilepsy are important issues
in the modern treatment of epilepsy. However, in many
cases depression remains unrecognized or untreated in both
children [7] and adults with epilepsy [3,8,9].
Patients with epilepsy can demonstrate classic symptoms
of a depressive disorder that meet the criteria for a DSM V
(Diagnostic and Statistical Manual of Mental Disorders, Fifth
Edition) or ICD-10 (10th revision of the International Classiﬁ-
cation of Diseases) diagnosis of depression or dysthymia. A
large proportion of interictal depression, however, does not
present in this manner and fails to meet criteria of any of the
DSM-III (Diagnostic and Statistical Manual of Mental Dis-
orders, Third Edition), DSM-IV (Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition), DSM V or ICD-
10 affective disorders [10,11]. Interictal depression in epileptic
patients frequently presents as a pleomorphic cluster of
symptoms of depression with an intermittent, chronic course.
Differences of the clinical manifestations of certain types of
depression between patients with epilepsy and nonepileptic
patients may be a cause of the underrecognition of depression
in patients with epilepsy. The development of new, improved
criteria of depression in ICD-11 (including organic mood
disorders) is actively ongoing [12]. In most studies evaluating
patients with epilepsy the prevalence of depression is
assessed by means of structured or semi-structured interviews
administered by trained investigators and not after clinical
interview with the qualiﬁed psychiatrist. Due to a pleomorphic
pattern of depressive symptoms diagnosis should be set by a
psychiatrist familiar with complex psychopathology of
patients with epilepsy.
The aim of our study was to assess the occurrence of
depressive symptoms and further evaluate different subtypes
of depressive disorders according to ICD-10 criteria in patients
with epilepsy and interictal depressive symptoms. The
additional aim was to ﬁnd an association between depressive
proﬁle and the type of epilepsy.
2. Material and methods
2.1. Study participants
Patients consecutively selected from the outpatient epilepsy
clinic, Department of Neurology of University Hospital in
Cracow between September 2009 and August 2010, entered
this study after giving informed consent. All patients underwent
previously a detailed clinical and laboratory investigation,
including electroencephalography or video-electroencephalog-
raphy (video-eeg) and high-resolution brain magnetic reso-
nance imaging (MRI) (or computed tomography if MRI was
contraindicated), so as to categorize their epilepsy syndrome
according to the 1989 International League Against Epilepsy
classiﬁcation [13]. Characterization of epilepsy and seizure type
relied on the assessment of the video-eeg data. If the video-eeg
was normal, subjects with a clinical diagnosis of simple or
complex partial seizures were considered to have focal epilepsy,whereas those with only generalized events were considered to
have an unknown epilepsy type. Inclusion criteria were age
older than 18 years, established epilepsy for >1year and signed
informed consent. Study exclusion criteria were as follows: (1)
history of psychogenic non-epileptic seizures, (2) history of drug
or alcohol abuse, (3) clinical seizure in the previous 72 h, as in
most cases ictal and post-ictal depressive symptoms ameliorate
within 2–3 days [14], (4) changes in antiepileptic drugs (AEDs)
regimen during the preceding month, (5) serious chronic
medical or neurological illnesses, (6) a Mini-Mental State
Examination (MMSE) <24, (7) moderate or severe mental
retardation (IQ < 50). Thereby, all patients with signiﬁcant
cognitive dysfunction were excluded from the study and
patients who entered the study had the cognitive capacity to
give informed consent and complete study questionnaires.
Demographic and clinical data were collected by interviews
and from information in patients' medical ﬁles. Information
including sex, age, marital status, education, occupation,
comorbidities, medication history, family history of epilepsy
and/or depression, epilepsy onset age, type of epilepsy, seizure
types and frequency, AEDs treatment, past history of psychiatric
illness or treatment was recorded by means of the question-
naire, created for that purpose. Previous diagnosis of depression
was coded as present if documented in the clinical record or if
the patient was currently taking antidepressant medication.
2.2. Protocol
All subjects were administered Beck Depression Inventory, 21
item version (BDI-II), a widely used and well validated 21-item
self-report inventory of depressive symptoms. BDI-II has been
recently tested in 205 patients with epilepsy from ﬁve epilepsy
centers and was found to have a high sensitivity and speciﬁcity
as a screening instrument of major depressive episode. Total
score >11 is suggestive of depressive disorders according to
the study of Jones and coworkers [15].
Patients who scored >11 in Beck Depression Inventory were
referred to a psychiatrist to conﬁrm a diagnosis of depression.
All patients with previous diagnosis of depression or taking
antidepressant medication were also referred to a psychiatrist.
Psychiatric diagnoses were made in accordance with ICD-10
[16] after clinical interviews with the qualiﬁed psychiatrists
from our team (D.D and M.S). All procedures were approved by
an institutional bioethical board.
2.3. Statistical analysis
The statistical analyses were performed using SPSS for
Windows v. 14. The Student's t-test was used for continuous
variables. The x2 test and Fisher exact test was used for
dichotomous and other categorical variables. p < 0.05 was
considered as signiﬁcant. Continuous data are presented as
mean  standard deviation (SD) while non-continuous vari-
ables are given as percentages.
3. Results
301 patients attending the outpatient epilepsy clinic of the
University Hospital in Cracow met inclusion criteria and
Table 1 – Cohort characteristics (289 patients).
Average age (years) 35.7 (14.9)
Male, n (%) 120 (41.52%)
Single 163 (56.40%)
Unemployed 178 (61.59%)
Average age at epilepsy onset 20.86 (15.24)
Duration of epilepsy (years) 14.67 (11.37)
Type of epilepsy
Idiopathic generalized 63 (21.80%)
Focal 189 (65.40%)
Unknown epilepsy type 37 (12.80%)
Seizure frequency
>1/week 58 (20.07%)
<1/week, >1/month 49 (16.96%)
<1/month, >1/year 92 (31.83%)
<1/year 90 (31.14%)
Epilepsy therapy
Monotherapy 161 (55.71%)
Polytherapy 128 (44.29%)
Table 3 – Prevalence data of current ICD-10 psychiatric
disorders in patients with depressive symptoms accord-
ing to BDI-II.
ICD diagnosis Number (%)
121 (100)
Organic mood [affective] disorders (F06.3) 38 (31.4)
Organic emotionally labile [asthenic]
disorder (F06.6)
1 (0.8)
Unspeciﬁed organic personality and
behavioral disorder due to brain disease,
damage and dysfunction (F07.9)
2 (1.7)
Persistent delusional disorders (F22) 1 (0.8)
Depressive episode (F32) 27 (22.3)
Mild depressive episode (F32.0) 14
Moderate depressive episode (F32.1) 13
Dysthymia (F34.1) 11 (9.1)
Recurrent depressive disorder (F33) 8 (6.7)
Recurrent depressive disorder, current
episode mild (F33.0)
7
Recurrent depressive disorder, current
episode moderate (F33.1)
1
Other mood [affective] disorders (F38) 1 (0.8)
Phobic anxiety disorders (F.40) 1 (0.8)
Mixed anxiety and depressive disorder (F41.2) 1 (0.8)
Adjustment disorders (F43.2) 9 (7.4)
Hypochondriacal disorder (F45.2) 1(0.8)
Neurotic disorder, unspeciﬁed (F48.9) 3 (2.5)
No psychiatric disorder 17 (14.1)
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who scored >11 in Beck Depression Inventory were referred to
a psychiatrist to conﬁrm a diagnosis of depression. 11 patients,
who scored >11 in BDI-II withdrew their consent for
psychiatric assessment, so they were excluded from further
analysis. 31 patients had previous diagnosis of depression,
they were currently treated with antidepressants, mostly with
selective serotonin re-uptake inhibitors (SSRIs). All of them
scored >11 in BDI-II. In total 121 patients underwent
psychiatric assessment. Final cohort consisted of 289 patients
(169 females, 120 males) ranging between 18 and 82 years of
age (mean = 35.7  14.9), most patients had focal seizures
(65.4%). Seizure frequency was lower than one per year in only
90 patients (31.14%); the remaining patients had higher seizure
frequency. Most patients (55.71%) were on one antiepileptic
drug. The most commonly used AEDs were valproate,
levetiracetam, carbamazepine, lamotrigin, topiramate and
oxcarbazepine. The mean BDI-II score in the whole cohort
was 11.53 (9.68). Table 1 lists the subject demographic and
seizure data, and Table 2 detailed information on epilepsy
treatment.Table 2 – Epilepsy therapy.
Monotherapy 161 (55.71%)
Polytherapy 128 (44.29%)
Speciﬁc anticonvulsant use
Valproate 171 (59.17%)
Levetiracetam 70 (24.22%)
Carbamazepine 62 (21.46%)
Lamotrigin 39 (13.43%)
Topiramate 38 (13.15%)
Oxcarbazepine 36 (12.46%)
Gabapentin 14 (4.84%)
Phenonobarbital 10 (3.46%)
Clonazepam 9 (3.11%)
Phenytoin 8 (2.77%)
Primidon 6 (2.08%)
Vigabatrin 2 (0.69%)
Tiagabine 2 (0.69%)
Ethosuximide 2 (0.69%)
Clobazam 1 (0.35%)104 (85.9%) patients who scored >11 in BDI-II had comorbid
mental disorders diagnosed during psychiatric interview,
according to ICD-10 criteria, whereas 17 (14.1%) patients did
not have any current ICD-10 diagnosis. The most common
were organic mood disorders (38 patients, 31.4%), depressive
episode (27 patients, 22.3%) and dysthymia (11 patients, 9.1%)
(Table 3). Among patients with depressive episode 14 suffered
from mild depression, 13 from moderate depression. In almost
all patients (7/8) with recurrent depressive disorder, current
episode was mild. In 31 patients with previous diagnosis of
depression, diagnosis was conﬁrmed in 23 patients (organic
mood disorders in 11, depressive episode in 9, recurrent
depressive disorder in 3). Of the remaining 8 patients, 4 had no
psychiatric disorder; unspeciﬁed organic personality and
behavioral disorder due to brain disease, damage and
dysfunction were diagnosed in 2 patients, persistent delusion-
al disorders in 1 and adjustment disorders in 1.
Depression (F32, F33 and F06.3) was diagnosed in 73
patients (60.3% of patients with BDI-II >11; 25.3% of the ﬁnal
cohort). The mean BDI-II score in patients with depression was
20.20 (6.94) and was signiﬁcantly higher than in the whole
cohort (p < 0.05). Table 4 presents types of depression in
patients with different epilepsy syndromes. There were no
differences in the prevalence of depression (p = 0.141) and
subtypes of depression in patients with certain epilepsy types
(p = 0.188).
10.4% patients (30 out of 289) had recent suicidal thoughts.
These patients marked the answers 1 (‘‘I have thoughts of
killing myself, but I would not carry them out’’ – 29 patients) or
2 (‘‘I would like to kill myself’’ – 1 patients) in question 9 of
the BDI. All patients with recent suicidal ideation scored >11
in BDI, the mean BDI score was 26 (7.82).
Table 4 – Subtypes of depression in epilepsy syndromes.
Diagnosis Idiopathic generalized epilepsy Focal epilepsy Unknown epilepsy type
Organic mood [affective] disorders (F06.3) 5 (45.4%) 29 (53.7%) 4 (50.0%)
Depressive episode (F32) 4 (36.4%) 20 (37.1%) 3 (37.5%)
Recurrent depressive disorder (F33) 2 (18.2%) 5 (9.2%) 1 (12.5%)
x2: p = 0.244.
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started on antidepressant drugs (SSRIs and SNRIs), in 3
patients additional psychotherapy was instituted (Table 5).
4. Discussion
In the present study of 289 epilepsy patients, 41.9% (121) of the
participants had abnormal BDI-II scores (>11), suggestive of
depressive disorders [15]. In comparison the mean BDI score in a
group of healthy men in Poland was 7.8. [17]. However,
depressive episode or recurrent depressive disorder was diag-
nosed in 73 (60.3%) patients which constitutes25.3% of the whole
cohort. The percentage is comparable to studies assessing
sample of patients with partial and generalized epilepsy [18,19].
There were no statistically signiﬁcant differences between
patients with different epilepsy types with respect to the
number of patients diagnosed with depression and separate
subtypes of depression. Previous studies found an increased
risk of depression in focal epilepsy, especially in temporal lobe
epilepsy when compared with other types of epilepsy [20,21].
However, most studies evaluating patients with mixed
epilepsy types did not ﬁnd signiﬁcant differences in the
prevalence of depression between patients with focal and
primarily generalized epilepsy [18,19,22,23]. Depression was
properly diagnosed and treated before entering the study in
only 23 (31.5%) patients with ﬁnal diagnosis of depression,
what is consistent with results of previous studies [9,10]. One
of the reasons for the lack of detection of depression in
patients with epilepsy appears to be the time pressure. The use
of psychometric tools that are self-administered, like BDI-II,
can help to resolve this problem. However, these devices do
not diagnose the presence of a depression but identify
symptoms that can be later categorized using DSM-V or
ICD-10 criteria. Yet, the process of diagnosis of depression
cannot be restricted to the completion of a rating scale. Self-
report methods as BDI have been designed for populations
other than patients with acquired brain damage, so their
diagnostic value in patients with epilepsy may be limited [24].Table 5 – Treatment instituted in patients with newly
diagnosed depressive disorder.
Treatment Number
Pharmacotherapy 50
Citalopram 25
Escitalopram 11
Fluoxetine 2
Sertraline 4
Paroxetine 4
Venlafaxine 4
Psychotherapy 3Patients with ‘‘high’’ scores should be subjected to a more
extensive and detailed evaluation. A deﬁnite diagnosis of
depressive disorder in epileptic patients can be a challenge
because a number of symptoms, which are recognized as
diagnostic criteria for a depressive episode by the ICD-10 and
DSM-V, may occur in temporal relation to seizures or
secondary to AED toxicity. Secondly, it is also established that
up to 70% of mood disorders identiﬁed in patients with
epilepsy present with atypical clinical characteristics that do
not meet any of the DSM Axis I categories [10]. Self-rating
scales, such as BDI-II, are useful to identify the presence of
depressive symptoms and quantify their severity. This type of
assessment must be followed by a referral for a complete
psychiatric interview to set the ﬁnal diagnosis, regarding
multifactorial contributors to psychiatric disturbances, in-
cluding effects of the underlying central nervous system
disorder, relation to seizures, medication effects and psycho-
social inﬂuences. Other scales or inventories such as Hamilton
Depression Rating Scale or Symptom Checklist-27-plus Ques-
tionnaire may be also useful [25]. Additional ﬁnding of our
study is high rate of suicidal ideation (10.4%) in patients with
epilepsy. This conﬁrms recent results from Hecimovic et al.
[25] and Jones et al. [26]. The rate of current suicidal thoughts
was approximately 12% in both studied cohorts.
There are several limitations to our study. First, not all
individual were referred to the psychiatrist. The possibility
remains that some patients, who scored <11 in BDI-II, suffered
from mild forms of depressive disorder. Second, a selection
bias toward patients with pharmacoresistant epilepsy in our
outpatient clinic may not be negligible. Third, a lack of control
groups, such as patients with other chronic neurological
disorders, or healthy control subjects, should be noted.
In conclusion, all subtypes of depressive disorders are
common in patients with epilepsy. While depression is
properly diagnosed only in one third of patients with epilepsy
it is crucial to recognize and treat these conditions.
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